AiCuris is one of the founding members of the newly launched alliance of Biotechs of Europe innovating in Anti-Microbial Resistance”, called the BEAM Alliance. This group of European biotechnology companies is committed to tackling the unique challenges facing the industry in the antibacterial field and currently regroups 37 companies from 10 European countries.
The BEAM Alliance will work to improve the regulatory, investment, and commercial environment for research, development and approval of new products combating antimicrobial resistance, as well as their market viability. The Alliance intends to provide a collective voice to biotech companies involved in developing innovative products to tackle antimicrobial resistance. By proposing and supporting policies and regulatory solutions to member-identified problems, BEAM aims to reinforce the attractiveness of this therapeutic area, support the development of new products and accelerate the market access of such new products for European patients. The BEAM Alliance was introduced for the first time at the ECCMID meeting 2015 in Copenhagen. The Pipeline corner session was taken up very well by the audience and media (http://www.news-medical.net/news/20150430/Novel-approaches-to-fight-infections-presented-at-the-Pipeline-Corner-at-ECCMID.aspx) and AiCuris is very happy to have participated with an ePoster.